Prevalence of anti-ulcer drug use in a Chinese cohort

Table 3 Total prescribed amount of anti-ulcer drugs by main ingredient from 1997 to 2001 (unit of measurement: numbers of defined daily doses [DDDs])

ATCa coding	Group/ingredient name	1997	1998	1999	2000	2001
A02BA H2 RA
	01 Cimetidine	114145	151403	221528	198255	221836
	02 Ranitidine	57329	62357	69780	69954	88034
	03 Famotidine	33366	40063	51198	52852	53108
	04 Nizatidine	8943	12304	12282	8269	5305
	06 Roxatidine	3493	3057	3215	2847	4460
A02BB Prostaglandins
	01 Misoprostol	2244	3649	5594	4534	1941
A02BC PPIS
	01 Omeprazole	26635	33587	46429	43589	57193
	02 Pantoprazole	-	14	2593	4845	9276
	03 Lansoprazole	5840	14276	19624	24860	31023
	04 Rabeprazole	-	-	-	-	864
A02BX Other drugs
	01 Carbenoxolone	5708	4164	4768	1945	1918
	02 Sucralfate	26172	20170	15942	10960	9898
	03 Pirenzepine	7575	7378	5925	3868	3942
	05 Bismuth subcitrate	7999	6104	5213	2686	2754
	06 Proglumide	1010	459	198	12	31
	07 Gefarnate	14379	17859	26568	16682	8972
	- Cetraxate	4072	1254	849	615	657
	- Urogastrone	5067	1272	1151	232	32
Total		323976	379370	492856	447005	501243
	Ambulatory sector	297213	355837	465326	420144	470924
	Inpatient sector	26764	23532	27530	26861	30319
DDDs/1000 inhabitants/day		4.9	5.7	7.3	6.5	7.5

^aATC = Anatomical therapeutic chemical classification system.